GenScript upgrades product packaging with a recyclable strategy, reducing waste by 82% and contributing to environmental sustainability

2025-01-15 IDOPRESS

PISCATAWAY,N.J.,Jan. 14,2025 -- GenScript Biotech Corporation has unveiled an innovation in shipping packaging,propelling GenScript towards achieving their ambitious sustainability goals. The new packaging replaces plastic with 100% recyclable paper materials,reducing waste by 82% and lowering annual carbon emissions by 5.14 tons,equivalent to the CO2 absorbed by ~250 trees.

The redesigned packaging also eliminates foam,relying on paper's structural strength,which is recyclable,minimizing the carbon footprint and waste compared to foam. The ink used in the printing is water-based,which is biodegradable and non-toxic,reducing waste and ecological impact.

Sherry Shao,Rotating CEO said: "GenScript is committed to corporate social responsibility. Our sustainable packaging programis a testament to our proactive approach inmanaging our environmental impact and empowering our customers to meet their environmental goals. We will continue to collaborate with all our partners to improve our supply chain and create a sustainable future for all."

The new packaging has passed various tests,including low-temperature shipping tests between multiple continents ensuring that shipping quality and outcomes will remain high. The new packaging has received positive customer feedback during preliminary testing. GenScript has upgraded 80% of its shipping boxes,with plans to upgrade all types.

In 2023,GenScript joined the United Nations Global Compact (UNGC) and integrated the UNGC principles into our strategic planning. In 2024,we received a bronze rating from EcoVadis for our environmental,social and governance practices. We also joined the Science-Based Targets initiative (SBTi) and submitted our emissions reduction targets,expecting SBTi's validation this year. The packaging program is part of our initiatives to achieve our net zero ambition by 2050.

About GenScript Biotech Corporation

Founded in 2002 in New Jersey,GenScript Biotech Corporation accelerates innovation in healthcare and consumer goods by providing researchers and companies with the building blocks needed to develop groundbreaking treatments and products. Guided by its mission to Make People and Nature Healthier Through Biotechnology,and its role as a trusted global leader,GenScript has a team of over 5,000 employees and has served more than 200,000 customers across 100 countries.

Learn more here: https://www.genscript.com

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright 2009-2020 Singapore Info Map